Members of the ID Division are involved in a wide array of innovative, interdisciplinary research programs that are dedicated to both advancing knowledge and fostering a culture of excellence in training the next generation of scientific leaders. In fiscal year 2016, the Perelman School of Medicine received $741.6 million in support of its research activities from extramural sponsors, including $392 million from the National Institutes of Health, ranking third in the nation among all academic medical institutions.
- Michael David (MRSA, healthcare associated infections, antibiotic resistance)
- Kathleen Degnan (Outpatient antibiotic stewardship)
- Lauren Dutcher (Antibiotic stewardship interventions, stewardship methods)
- Keith Hamilton (Healthcare Epidemiology; Antimicrobial Stewardship; Non-tuberculous mycobacterial infections)
- Jerry Jacob (Infections in long-term care facilities)
- Ebbing Lautenbach (antibiotic use, antimicrobial resistance, healthcare-associated infections, epidemiologic methods in the study of infectious diseases)
- Anne Norris (Outpatient Parenteral Antimicrobial Agents, safe and effective transition from hospital to home; use of electronic technologies in healthcare)
- Judith O'Donnell (hospital infection control, epidemiology of healthcare associated infections)
- David Pegues (microbiology testing and antimicrobial therapy, strategies to reduce environmental microbial, epidemiology and prevention of infections in solid organ transplant recipients.
- Naasha Talati (latent tuberculosis infection; antimicrobial stewardship)
- Matt Ziegler (Infections in hematologic malignancy patients, environment microbiome)
- Emily Blumberg (Infections in transplant recipients)
- Mindy Schuster (infections in cancer patients; fungal infections)
- Matt Ziegler (Infections in hematologic malignancy patients, environmental microbiome)